News Digest / Ticker: REGN

Ticker: REGN

07:00am, Friday, Aug 01, 2025

Regeneron Reports Q2 2025 Growth Amid Declining Product Sales and Rising Expenses

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) recently reported its financial performance for the second quarter of 2025. Here's a concise overview of the highlights from their income statement along with pertinent company insights: Positive Aspects: Revenues: Total revenues increased to $3,675...